Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health

University of Toronto

$100,000.00

Glucocorticoid regulation of the catabolic effects of parathyroid hormone in bone

FY 2008-09

Summary
Glucocorticoids are a group of steroid drugs that are used to treat inflammatory conditions such as asthma, arthritis and inflammatory bowel disease. One of the major side-effects of these drugs is osteoporosis in which the bones become weak and prone to fracture. Research has shown that glucocorticoids alter the response of bone cells to endogenous hormones resulting in less bone deposition and eventual osteoporosis. We have examined the effects of glucocorticoids on osteoblasts, the cells that make bone, and found that they alter the responses to hormones such and parathyroid hormone (PTH). In our current work we will continue to identify the key changes to signaling in osteoblasts and test the effects of these changes in mouse models. By understanding these changes we may be able to find ways to avoid osteoporosis when patients have to take steroid antiinflammatory drugs.
Program
Operating Grant - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
176420
Name
Mitchell Jane A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Clinical Investigation - B: Arthritis, Bone, Skin and Cartilage
Projecttitle
Glucocorticoid regulation of the catabolic effects of parathyroid hormone in bone
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health
Keyworddelim
Beta-Adrenergic Agonists; Bone; Glucocorticoids; Osteoporosis; Parathyroid Hormone; Transcription Factors
Abstract
Glucocorticoids are a group of steroid drugs that are used to treat inflammatory conditions such as asthma, arthritis and inflammatory bowel disease. One of the major side-effects of these drugs is osteoporosis in which the bones become weak and prone to fracture. Research has shown that glucocorticoids alter the response of bone cells to endogenous hormones resulting in less bone deposition and eventual osteoporosis. We have examined the effects of glucocorticoids on osteoblasts, the cells that make bone, and found that they alter the responses to hormones such and parathyroid hormone (PTH). In our current work we will continue to identify the key changes to signaling in osteoblasts and test the effects of these changes in mouse models. By understanding these changes we may be able to find ways to avoid osteoporosis when patients have to take steroid antiinflammatory drugs.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mitchell, Jane A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~